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Abstract
Background: Control selection is a major challenge in epidemiologic case-control studies. The aim of our study was to
evaluate using hospital versus neighborhood control groups in studying risk factors of esophageal squamous cell carcinoma
(ESCC).
Methodology/Principal Findings: We compared the results of two different case-control studies of ESCC conducted in the
same region by a single research group. Case definition and enrollment were the same in the two studies, but control
selection differed. In the first study, we selected two age- and sex-matched controls from inpatient subjects in hospitals,
while for the second we selected two age- and sex-matched controls from each subject’s neighborhood of residence. We
used the test of heterogeneity to compare the results of the two studies. We found no significant differences in exposure
data for tobacco-related variables such as cigarette smoking, chewing Nass (a tobacco product) and hookah (water pipe)
usage, but the frequency of opium usage was significantly different between hospital and neighborhood controls.
Consequently, the inference drawn for the association between ESCC and tobacco use did not differ between the studies,
but it did for opium use. In the study using neighborhood controls, opium use was associated with a significantly increased
risk of ESCC (adjusted OR 1.77, 95% CI 1.17–2.68), while in the study using hospital controls, this was not the case (OR 1.09,
95% CI 0.63–1.87). Comparing the prevalence of opium consumption in the two control groups and a cohort enrolled from
the same geographic area suggested that the neighborhood controls were more representative of the study base
population for this exposure.
Conclusions/Significance: Hospital and neighborhood controls did not lead us to the same conclusion for a major
hypothesized risk factor for ESCC in this population. Our results show that control group selection is critical in drawing
appropriate conclusions in observational studies.
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Introduction
Case-control studies are the design of choice in studying less
common diseases such as esophageal cancer. Although esophageal
cancer ranks 8
th in incidence amongst all cancers [1], it is rare
enough that even in many large cohorts, it may take a long time to
have enough numbers of cases sufficient for statistical analysis
[2,3,4]. Therefore, although consortia of cohorts can help to have
enough numbers of cases, case-control studies are still widely used
to study the etiology of esophageal cancer.
Defining an appropriate sampling frame from which controls
should be selected is arguably one of the most difficult tasks in
designing a case-control study. The aim is to select a group of
controls which are representative of the community from which
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32711cases have been selected. In their review of the methodological
issues of case-control studies, Wacholder and colleagues have
stressed the importance of study base and control selection in case-
control studies, and discussed several sources for control selection,
including population controls, hospital or disease registry controls,
controls from a medical practice, friend controls, relative controls,
controls selected from case series, proxy respondents and deceased
controls [5]. Neighborhood and hospital-based controls have been
used in many studies. Each of these controls has advantages and
disadvantages. For example, enrolling hospital controls is usually
more convenient and less costly, and information collected from
cases and controls is more comparable in the sense that both cases
and controls respond in a medical setting, but it also has the
disadvantage that cases and controls may not be from the same
study base and the referral pattern for the disease of interest may
be different. A comprehensive treatment of this subject is given
elsewhere [6].
The Golestan Case-Control Study in northeastern Iran was
carried out in two phases. In the pilot phase of the study, 130
incident esophageal squamous cell carcinomas (ESCCs) and 260
matched hospital controls were enrolled, while in the main phase
of the study, 300 ESCC cases and 571 matched neighborhood
controls were recruited [7]. In this manuscript, we compare the
results obtained from the pilot phase of this study, which used
hospital controls, and the results of the main phase, which used
neighborhood controls, to evaluate tobacco-related variables and
opium as risk factors for ESCC.
Methods
Ethics Statement
The study was approved by the Institutional Review Boards of
the Digestive Disease Research Center of Tehran University of
Medical Sciences and the US National Cancer Institute.
Case Selection
This study compares results from the pilot phase (March 2002–
November 2003) and the main phase (December 2004–June 2007)
of the Golestan Case-Control Study. Case selection and
procedures in the pilot phase and the main phase of the study
were the same. A detailed description of the case selection
procedures has been published [8]. All cases were evaluated at
Atrak Clinic in Khatam Hospital, located in Gonbad City, which
is the only specialized clinic for upper gastrointestinal tract cancers
in Golestan Province. Patients suspected of having upper
gastrointestinal tract cancers were referred by local physicians to
the clinic. A population-based cancer registry confirmed that
about 70% of incident ESCC cases visited Atrak. All suspected
cases underwent upper gastrointestinal endoscopy. Biopsy samples
of the esophagus taken during endoscopy were reviewed by expert
pathologists at the Digestive Disease Research Center, Tehran
University of Medical Sciences. All cases enrolled in both phases
had pathology-proven esophageal squamous cell carcinoma.
Control Selection
Hospital-based controls in the pilot phase
study. Hospitalized subjects were individually matched to
each case on age and sex. Because tobacco use, alcohol
consumption, and diet are thought to be important risk factors
for ESCC [9], controls were selected from inpatient subjects with
diseases thought to be unrelated to tobacco use, alcohol
consumption, or diet. When a case was diagnosed, the control
selection team reviewed the list of the patients in hospital wards,
especially trauma wards, prepared a roster of potential sex- and
age-matched (62 years) controls and randomly selected two
patients. If either of the selected controls refused or was too ill to
participate, the team selected another control from the roster.
Control selection matched the expected pattern of cases presenting
to the local hospitals. Most (78.5%) of the controls were selected
from Khatam hospital, where Atrak Clinic is located, and the rest
of the controls were selected from other hospitals in Gonbad City.
The response rate for hospital controls was 95% of the first
selected patients.
Neighborhood controls in the main phase study.
Neighborhood controls were selected using the Iranian Family
Health Census as the sampling frame. Two subjects were matched
to each case by place of residence (urban neighborhood or village),
age (62 years), and sex. The interview team identified all of the
potentially eligible controls in the case’s village or urban area, and
randomly selected two subjects to interview. If either of the selected
controls could not be interviewed for any reason, another person on
the list was randomly invited, and so forth. The total number of
enrolled neighborhood controls was 571. Of the enrolled
neighborhood controls 77% were the first randomly selected
subjects, 11% were the second, and the remainder required more
than two selections. In nearly all instances the reason that an eligible
control did not participate in the study was the absence of the
control at the time of invitation [10].
Data Collection
After obtaining written informed consent, a structured ques-
tionnaire with closed questions and pre-categorized responses was
administered to both cases and controls by physician-researchers
from Atrak Clinic. The questionnaire included detailed informa-
tion on demographics, family history of cancer, history of tobacco,
opium and alcohol use, drinking tea habits, oral health, and
socioeconomic variables. More detailed information on the
questionnaire is available elsewhere [8].
Statistical Analysis
Univariate and multiple variable conditional logistic regression
models were used to measure crude and adjusted odds ratios (OR)
and 95% confidence Intervals (CI). In addition to the matching
factors of age, sex, and place of residence, we also adjusted for
education (as a determinant of socioeconomic status), ethnicity
(Turkmen versus non-Turkmen) and consumption of cigarette,
hookah, Nass and opium (for those analyses that these were not the
main independent variable). We chose two previously identified
risk factors for ESCC for comparing the two studies, use of
different forms of tobacco and use of opium. We calculated the p-
value of the heterogeneity test for each set of adjusted ORs. For
significant differences between the two sets of controls, we also
compared data from our two controls series with the data from the
Golestan Cohort Study, a large cohort study conducted in the
same geographic area [11,12]. Age, sex and ethnicity distributions
of the two control sets and the cohort were different from each
other, so we used the cohort population as the standard population
and used the indirect standardization method to calculate
expected (standardized) prevalence rates for the other groups.
Results
A total of 130 ESCC cases and 260 hospital-based controls were
enrolled in the pilot phase of the study, while the corresponding
numbers of cases and neighborhood controls in the main phase of
the study were 300 and 571, respectively. Demographic
characteristics of the studies participants are shown in Table 1.
Control Selection in Case Control Studies
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similar between the cases in the two studies, but hospital-based
controls were more likely to be non-Turkmen and live in the urban
areas than the cases or the neighborhood controls.
Tables 2, 3, 4, 5, 6 show the exposure distributions among
cases and controls in the two phases of the study. Crude and
adjusted ORs and 95% CIs are presented for each phase of the
study. Table 2 shows the results for smoking cigarettes. The
striking feature of this table and the related results is the overall
very low prevalence of smoking in this population, across cases,
hospital controls and population controls and these rates were
lower in the hospital-based study; 13% of the controls in the
hospital-based study and 17% of the controls in the neighborhood-
based study smoked cigarettes. However, the ORs were compa-
rable in the two studies. Both studies showed an increase in the risk
of ESCC with smoking, with an adjusted OR of less than 1.5.
They also showed a dose-response trend with cumulative use of
cigarettes.
Table 3 shows the results for Nass use. The results were nearly
identical in the two studies. Approximately 8 to 9% of the controls
used Nass in each study, and in both, the adjusted ORs show that
Nass use was associated with a 1.5–1.8-fold increased risk of
ESCC.
The results for hookah are shown in Table 4. Only 7% of the
controls in the pilot phase of study and 4% of the controls in the
main phase of the study used hookah. The point estimates for the
adjusted ORs were 1.8–2.1.
Table 5 shows the results for opium use. Twenty-eight percent
of the hospital-based controls but only 18% of the neighborhood-
based controls reported using opium. However, the percentage of
ESCC patients who used opium was quite similar in the two
phases of the study (35% and 30%, respectively) (P value.0.05).
The adjusted ORs were greater than 1 in both studies, while the
OR was significant and much higher in the neighborhood-based
study (OR 1.77) than in the hospital-based study (OR 1.09), it may
make sense even though test of heterogeneity is not significant.
Additionally, duration of use showed a dose-response association
with ESCC risk in the neighborhood-based study, whereas it did
not show such an association in the hospital-based study. In the
hospital-based study, the questionnaire did not include average
amount of opium used each day, so data on average amount and
cumulative exposure were not available.
Calculated standardized opium consumption prevalence’s were
0.17, 0.16 and 0.23 for the cohort subjects, the neighbourhood
controls and the hospital controls, respectively. We also pooled the
data of the 430 cases from the two phases of the study and
compared this pooled case data with that of the neighborhood
controls and the hospital based controls separately, using non-
conditional logistic regression. The results showed that in the
analysis of the 430 cases and 570 neighbourhood controls, after
adjusting for the confounding factors, using opium had a
significant association with ESCC (OR=2.05, 95% CI 1.43–
2.93) while in the analysis of the 430 cases and 260 hospital
controls, it did not (OR=0.87, 95% CI 0.57–1.33).
Table 6 shows that among both sets of controls, that smoking is
by far the strongest determinant of opium use. Smoking is also a
very strong determinant of ESCC, and so opium must be
considered a confounder of the relationship between smoking
and ESCC, and vice versa. Considering the results of table 6 we
add a multivariable analyses in table 5, assessing opium as a risk
factor for ESCC which has been adjusted for smoking. The results
showed that the observed association with opium use cannot be
explained by confounding effect of smoking.
Discussion
In this study, we compared the associations of tobacco-related
variables and opium use with ESCC risk in two phases of a case-
control study in the same population, one phase using hospital
controls and one using neighbourhood controls. We found that the
results were similar for cigarette smoking and Nass consumption in
the two phases of study; both showed a similar magnitude of
Table 1. Demographic Characteristics of ESCC cases and controls in the two phases of the Golestan Case-Control Study of ESCC in
Golestan Province, Iran.
Hospital study Neighborhood study Difference in controls
ESCC
N( % )
Controls
N( % )
ESCC
N( % )
Controls
N( % )
Total 130 260 300 571
Gender
Male 79 (61) 158 (61) 150 (50) 278 (49) P value,0.05
Female 51 (39) 102 (39) 150 (50) 293 (51)
Age
,=50 22 (17) 40 (15) 32 (11) 61 (11) P value,0.05
51–60 29 (22) 60 (23) 81 (27) 144 (25)
61–70 38 (29) 83 (32) 86 (29) 177 (31)
.70 41 (32) 77 (30) 101 (34) 189 (33)
Ethnicity
Turkmen 72 (55) 94 (36) 171 (57) 312 (55) P value,0.05
Non-Turkmen 58 (45) 166 (64) 129 (43) 259 (45)
Residence
Urban 37 (29) 109 (42) 82 (27) 150 (26) P value,0.05
Rural 93 (71) 151 (58) 218 (73) 421 (74)
doi:10.1371/journal.pone.0032711.t001
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hookah use, as the prevalence of consumption in the study area is
very low and our sample size was modest. We found a notable
difference between the pilot and main phase results, however,
when examining the effect of opium use. Compared to the
neighbourhood controls, hospital-based controls were more likely
to use opium, at rates close to those seen in cases. Therefore, while
the neighborhood-based study showed an increased risk of ESCC
with opium use, the hospital-based study did not.
Whether hospital-based or population-based controls better
satisfy the comparability criteria has been long debated in
epidemiologic texts and articles [13]. As Miller and colleagues
have discussed, the answer may depend on the question(s) asked,
and each study must evaluate the circumstances individually [14].
There are a number of studies which have compared these two
methods of control selection. In a case-control study of cervical
cancer, where the exposures were variables related to pregnancy,
marital status, intercourse, and smoking, West and colleagues
showed that hospital controls were more ‘case like’ than
population controls for all exposures, and this led to underesti-
mating the effects [15]. In a case-control study of diet and
colorectal cancer, however, there were no significant differences in
conclusions using hospital or population controls, so that for most
analyses the authors combined the two series [16]. In another
study, Sadetzki and colleagues mentioned that the possibility of
selection bias should be taken into consideration whenever hospital
controls are used [17]. In one other study [18], Infante-Rivard
compared population and hospital controls to study risk factors of
leukemia in children. From comparisons with population survey
data and socioeconomic data, this researcher concluded that the
study groups came from the same base population but the
distribution of exposures in hospital controls was closer to that of
cases than those of population controls, which resulted in ORs
closer to null when using hospital controls [18].
In the current study, the prevalence of smoking among the
hospital controls was close to that of the neighborhood controls,
and also close to that found in the pilot phase of the Golestan
Cohort Study in the same population [11]. The ORs in the two
case-control studies were similar, and from both we would
conclude that cigarette smoking is a risk factor for ESCC, albeit
more modestly than it is in other populations [19]. The hospital
controls were mostly selected from patients admitted for elective
surgery (73%) or trauma (21%), but there were internal medicine
patients (6%) too. These conditions were selected under the
assumption that they were not related to smoking. Most of the
surgery patients were hospitalized for benign prostatic hyperplasia
(BPH) or hernia. , There is a possible but controversial protective
effect of low dose smoking on BPH [20], but the association, if it
exists, is small and would be unlikely to affect our results. There is
also a report that has shown an association between smoking and
hernia [21] but it needs to be investigate more to find out the real
association between smoking and hernia.
Table 2. Cigarette use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in
Golestan Province, Iran.
Hospital study Neighborhood study
Pf o r
heterogeneity
adjusted ORs
ESCC
%
Control
%
Crude
OR (95% CI)
Adjusted*
OR (95% CI)
ESCC
%
Control
%
Crude
OR (95% CI)
Adjusted*
OR (95% CI)
Cigarette Smoking
Never 107(82) 226(87) 1.00 1.00 232(78) 471(83) 1.00 1.00
Ever 23(18) 34(13) 1.48 (0.80–2.75) 1.33(0.67–2.64) 67(22) 99(17) 1.35 (0.92–2.00) 1.05(0.67–1.64) 0.59
Average amount
(cigarettes per day)
Never Used 107(82) 226(87) 1.00 1.00 232(78) 471(83) 1.00 1.00
,=Median** 10(8) 20(8) 1.09 (0.48–2.49) 1.04(0.42–2.61) 22(7) 49(9) 0.89 (0.51–1.56) 0.75(0.41–1.38) 0.56
.Median 13(10) 14(5) 2.06 (0.90–4.71) 1.71(0.68–4.27) 45(15) 50(9) 1.84 (1.13–2.99) 1.38(0.80–2.37) 0.70
Duration
Never Used 107(82) 226(87) 1.00 1.00 232(78) 471(83) 1.00 1.00
,=Median 16(12) 19(7) 1.96 (0.90–4.28) 1.64(0.72–3.69) 30(10) 49(9) 1.18 (0.72–1.94) 0.88(0.50–1.52) 0.29
.Median 7(6) 15(6) 0.99 (0.38–2.55) 0.94(0.33–2.62) 37(12) 50(9) 1.58 (0.95–2.62) 1.27(0.73–2.23) 0.58
Cumulative***
Never Used 107(82) 226(87) 1.00 1.00 232(78) 471(83) 1.00 1.00
,=Median 10(8) 17(6.5) 1.30 (0.55–3.07) 1.22(0.47–3.19) 30(10) 49(9) 1.22 (0.74–2.01) 1.00(0.58–1.73) 0.73
.Median 13(10) 17(6.5) 1.66 (0.76–3.62) 1.42(0.59–3.40) 37(12) 50(9) 1.52 (0.91–2.53) 1.11(0.62–1.98) 0.66
Age Started
Never Used 107(82) 226(87) 1.00 1.00 232(78) 471(83) 1.00 1.00
.Median 10(8) 17(6.5) 1.26 (0.54–2.91) 1.01(0.41–2.48) 23(8) 49(9) 0.98 (0.57–1.68) 0.84(0.47–1.50) .75
,=Median 13(10) 17(6.5) 1.76 (0.76–4.06) 1.75(0.72–4.25) 44(15) 50(9) 1.75 (1.08–2.84) 1.28(0.74–2.20) .58
*Adjusted for opium, nass, hookah, ethnicity, education and place of residence.
**Median of control group in each set.
***Cumulative=duration6amount.
doi:10.1371/journal.pone.0032711.t002
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similar, but it was higher than what was found in the pilot phase of
the Golestan Cohort Study pilot phase of the cohort study (19).
However, we should not expect that the prevalence in the case-
control and cohort studies should be similar, since Nass use is a
function of sex, age, and ethnicity (it is most commonly seen in
Turkmen men), and the case-control and cohort studies were
dissimilar in these demographic variables.
The pattern of association with hookah use was reasonably
similar in the two phases of the study. However, as we mentioned
above, the number of people who used hookah was very small, so
it is difficult to draw any meaningful conclusions.
The main difference between two studies was related to the
association of opium consumption and ESCC risk. The cases in
both studies had similar rates of opium consumption, but the
hospital controls reported a higher prevalence of opium use than
the neighborhood controls. So OR for opium use in neighbour-
hood control set is significant while it is not statistically significant
in hospital control set and although test of heterogeneity was not
significant, considering that the power of analysis in interaction
test is not high enough we think that P value of 0.15 can be an
issue for discussion.
There are several potential explanations for this difference in
prevalence among these two control groups. Hospital controls may
not be representative of the population because in this area opium
has traditionally been used to treat pain and numerous ailments,
including those which brought some of these controls to the
hospital. In addition, a recent study has shown that regular users of
opium are more prone to accidents [22]. This report is consistent
with our finding that 48% of the hospital control patients admitted
for trauma used opium. If either of these hypotheses is true, then
using hospital controls would result in Berksonian bias and, in this
instance, the estimation of opium risk would be biased toward the
null. On the other hand the slight differences in ORs between the
two studies can not necessarily be due to control selection as there
are many differences between the two case-control studies.
Different case groups and twice as many cases in the neighbor-
hood study than the hospital-based study (the hospital-based
estimates are less robust) can inflating opium exposure in this
control group.
We compared standardized rates of opium use among the two
sets of controls in the current study and the participants in the
Golestan Cohort Study, which is the most representative survey
that we have of the community from which the cases were
selected, and we found that the prevalence of opium use in the
cohort was much closer to that in the neighbourhood controls than
it was to the prevalence of opium use in the hospital controls. This
suggests that the neighbourhood controls were more representa-
tive of the study base than the hospital controls, at least for opium
exposure. On the other hand, one might argue that the reported
rates of opium consumption among neighborhood controls and
participants in the cohort are lower than the real rates because
Table 3. Nass use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in Golestan
Province, Iran.
Hospital study Neighborhood study
Pf o r
heterogeneity
adjusted ORs
ESCC
%
Control
%
Crude
OR (95% CI)
Adjusted*
OR (95% CI)
ESCC
%
Control
%
Crude
OR (95% CI)
Adjusted*
OR (95% CI)
Nass
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
Ever 20(15) 23(9) 1.89 (0.98–3.62) 1.82(0.89–3.70) 44(15) 48(8) 2.09 (1.28–3.42) 1.53(0.88–2.64) 0.71
Average amount
(times per day)
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
,=Median** 11(8) 12(5) 2.05 (0.85–4.93) 1.93(0.76–4.92) 17(6) 24(4) 1.59 (0.78–3.25) 1.11(0.52–2.39) 0.42
.Median 9(7) 11(4) 1.74 (0.71–4.22) 1.71(0.66–4.40) 27(9) 24(4) 2.52 (1.38–4.61) 1.90(0.98–3.66) 0.85
Duration
Never 110(85) 237(91) 1.00 256(85) 523(92) 1.00 1.00
,=Median 10(7.5) 13(5) 1.65 (0.67–4.06) 1.43(0.54–3.76) 26(9) 24(4) 2.44 (1.32–4.49) 1.69(0.87–3.26) 0.77
.Median 10(7.5) 10(4) 2.19 (0.85–5.65) 2.35(0.86–6.41) 18(6) 24(4) 1.69 (0.83–3.41) 1.33(0.62–2.81) 0.43.
Cumulative***
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
,=Median 9(7) 12(5) 1.61 (0.64–4.04) 1.42(0.50–3.95) 22(7) 25(4) 2.19 (1.08–3.73) 1.36(0.70–2.66) 0.95
.Median 11(8) 11(4) 2.20 (0.89–5.39) 2.25(0.86–5.85) 22(7) 23(4) 2.20 (1.15–4.21) 1.74(0.86–3.53) .68
Age Started
Never 110(85) 237(91) 1.00 1.00 256(85) 523(92) 1.00 1.00
.Median 12(9) 12(5) 1.56 (0.60–4.02) 1.65(0.59–4.55) 25(8) 27(5) 2.07 (1.06–4.04) 1.49(0.73–3.04) 0.88
,=Median 8(6) 11(4) 2.20 (0.93–5.18) 1.95(0.80–4.74) 19(6) 21(4) 2.11 (1.13–3.94) 1.56(0.79–3.06) 0.70
*Adjusted for cigarette smoking, opium and hookah consumption, ethnicity, education and place of residence.
**Median of control group in each set.
***Cumulative=duration6amount.
doi:10.1371/journal.pone.0032711.t003
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Iran.
Hospital study Neighborhood study
Pf o r
heterogeneity
adjusted ORs
ESCC% Control%
Crude
OR(95% CI)
Adjusted**
OR (95% CI)
ESCC
%
Control
%
Crude
OR (95% CI)
Adjusted**
OR (95% CI)
Hookah
Never 119(92) 243(93) 1.00 1.00 280(93) 548(96) 1.00 1.00
Ever 11(8) 17(7) 1.33 (0.59–3.00) 2.15(0.91–5.08) 20(7) 23(4) 1.81 (0.95–3.43) 1.79(0.90–3.55) 0.79
Average amount (times
per day)
Never Used 119(92) 243(93) 1.00 1.00 280(93) 548(96) 1.00
,=Median** 5(4) 13(5) 0.81 (0.27–2.35) 1.33(0.44–3.98) 11(4) 18(3) 1.29 (0.59–2.84) 1.30(0.56–3.03) 0.97
.Median 6(4) 4(2) 2.94 (0.82–10.5) 5.78(1.25–26.59) 9(3) 5(1) 3.51 (1.17–10.5) 3.23(1.04–9.96) 0.60
Duration
Never Used 119(92) 243(93) 1.00 1.00 280(93) 548(96) 1.00 1.00
,=Median 9(7) 9(4) 1.91 (0.75–4.85) 3.43(1.25–9.43) 15(5) 12(2) 2.52 (1.14–5.55) 2.39(1.03–5.57) 0.61
.Median 2(1) 8(3) 0.55 (0.11–2.64) 0.77(0.15–3.87) 5(2) 11(2) 1.00 (0.34–2.90) 1.10(0.37–3.30) 0.70
Cumulative***
Never Used 119(92) 243(93) 1.00 1.00 280(93) 548(96) 1.00 1.00
,=Median 9(7) 9(4) 1.93 (0.76–4.89) 3.26(1.20–8.80) 12(4) 12(2) 2.07 (0.87–4.88) 1.95(0.77–4.87) 0.48
.Median 2(1) 8(3) 0.50 (0.09–2.55) 0.77(0.14–4.06) 8(3) 11(2) 1.55 (0.62–3.87) 1.64(0.63–4.25) 0.39
Age Started
Never Used 119(92) 243(93) 1.00 1.00 280(93) 548(96) 1.00 1.00
.Median 4(3) 9(4) 0.92 (0.27–3.16) 1.29(0.36–4.54) 7(2) 11(2) 1.55 (0.62–3.87) 1.26(0.45–3.48) 0.97
,=Median 7(5) 8(3) 1.74 (0.62–4.81) 3.26(1.08–9.76) 13(4) 12(2) 2.22 (0.99–5.00) 2.33(0.97–5.60) 0.65
*Adjusted for cigarette smoking, opium, nass, ethnicity, education and place of residence.
**Median of control group in each study.
***Cumulative=duration6amount.
doi:10.1371/journal.pone.0032711.t004
Table 5. Opium use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in
Golestan Province, Iran.
Hospital study Neighborhood study
Pf o r
heterogeneity
adjusted ORs
ESCC% Control%
Crude
OR(95% CI)
Adjusted**
OR(95% CI)
ESCC
% Control %
Crude
OR(95% CI)
Adjusted**
OR(95% CI)
Opium
Never 85(65) 187(72) 1.00 1.00 210(70) 465(81) 1.00 1.00
Ever 45(35) 73(28) 1.37 (0.85–2.21) 1.09(0.63–1.87) 90(30) 106(18) 1.95 (1.36–2.78) 1.77(1.17–2.68) 0.15
Duration
Never 85(65) 187(72) 1.00 1.00 210(70) 465(81) 1.00 1.00
,=Median** 27(21) 36(14) 1.69 (0.94–3.05) 1.48(0.78–2.81) 34(11) 53(9) 1.44 (0.88—2.39) 1.44(0.84–2.45) 0.94
.Median 18(14) 3714 1.05 (0.54–2.03) 0.73(0.35–1.51) 56(19) 53(9) 2.37 (1.54—3.65) 2.12(1.28–3.50) 0.02
Age Started
Never 85(65) 187(72) 1.00 1.00 210(70) 465(81) 1.00 1.00
.Median 26(20) 39(15) 1.33 (0.74–2.41) 1.07(0.54–2.10) 41(14) 53(9) 1.26 (0.74—2.16) 1.25(071–2.18) 0.72
,=Median 19(15) 34(13) 1.42 (0.73–2.7) 1.11(0.55–2.27) 49(16) 53(9) 2.5 (1.63—3.84) 2.32(1.40–3.82) 0.09
*Adjusted for cigarette smoking, nass, hookah, ethnicity, education and place of residence.
**Median of control group in each study.
doi:10.1371/journal.pone.0032711.t005
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sick, so they may not answer the questions as truthfully, and this
may result in information bias. However, a recent study by our
group showed that the responses given to the questions in the pilot
phase of the cohort study, also in a non-medical setting, were very
close to the results found by testing urine for markers of codeine
and morphine [23], so it seems that the questionnaire provides
valid responses in this setting.
This study has several strengths and limitations. Notable
strengths, especially for the comparisons in this paper, were the
high participation rates of both hospital and neighbourhood
controls and the fact that the same team members interviewed all
the cases and controls in both studies. One of the limitations is the
modest sample size of the hospital-based study. Another is the fact
that we cannot exclude the possibility that some of the exposures
under study (particularly opium use) might be associated with the
reasons that the hospital controls were hospitalized.
In summary, the results of this study show that neighbourhood
controls were superior to hospital controls in assessing the risk of
ESCC associated with opium exposure in this population. But, as
Table 6. Determinants of opium use in hospital and neighborhood controls in the two phases of the Golestan Case-Control Study
in Golestan Province, Iran.
Hospital* Neighborhood* Combined**
OR 95% CI OR 95% CI OR 95% CI
sex
male 1 1 1
female 0.19" 0.08–0.48 0.88 0.47–1.67 0.56{ 0.34–0.92
age
Above 70 1 1 1
60–70 1.04 0.46–2.34 0.96 0.53–1.74 0.93 0.58–1.48
50–60 0.87 0.34–2.25 1.14 0.57–2.27 1 0.58–1.72
30–50 1.57 0.43–5.73 0.52 0.17–1.60 0.64 0.29–1.42
ethnicity
Turkmen 1 1 1
non-Turkmen 0.87 0.42–1.76 2.42" 1.42–4.13 1.74{ 1.15–2.65
place of residence
urban residence 1 1 1
rural residence 2.18{ 1.02–4.67 1.82 0.97–3.45 1.90{ 1.18–3.06
marital status
Married 1 1 1
widowed/divorced 0.75 0.29–1.93 1.49 0.74–3.01 1.20 0.69–2.09
education
illiterate 1 1 1
elementary 0.78 0.31–1.94 1.48 0.69–3.19 1.20 0.68–2.12
middle school and above 0.29 0.05–1.78 0.62 0.20–1.91 0.56 0.22–1.39
home ownership
owned 1 1 1
tenant 0.83 0.16–4.36 2.2 0.52–9.34 1.16 0.39–3.51
Smoking
never smoked 1 1 1
smoker 8.92" 3.40–23.45 12.30" 6.59–22.98 9.34" 5.76–15.17
History of chronic diseases
Absent 1 1 1
Present 2.06 0.98–4.34 1.32 0.80–2.20 1.36 0.91–2.05
Source of controls
Hospital - - - - 1
Neighborhood - - - - 0.49" 0.32–0.75
*Model includes all the variables in the table except source of controls;
**model includes all the variables in the table.
OR: odds ratio; CI: Confidence interval;
{p,0.05;
{p,0.01;
"p,0.001.
doi:10.1371/journal.pone.0032711.t006
Control Selection in Case Control Studies
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e32711shown in this and other studies, both hospital and neighbourhood
controls can bring biases into an evaluation. Optimal control
group selection requires considerable thought, and the best control
group may be different in different studies.
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